Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Emphysema, a lung disease that millions of Canadians currently suffer from, has few safe and non-invasive options available. One of the features of emphysema is the lack of proper blood flow in the diseased lungs and this results in poor gas exchange. IKOMED Technologies Inc. has been developing a new technology that has the potential to remove diseased lungs non-surgically. The initial proof-of-concept experiments have already been tested and validated using rat models with Dr. Don Sin. In the second phase of testing, they will continue to optimize this application using small mice for physiological studies to check both safety and effectiveness of this new treatment method. IKOMED Technologies Inc. is the sponsor of this work and will be acknowledged in potential publications. The data collected may be used for future patenting of this new treatment technology.
IKOMED Technologies Inc
Find the perfect opportunity to put your academic skills and knowledge into practice!Find Projects
The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.